Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection againstStaphylococcus aureusPneumonia
- 1 July 2009
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 77 (7), 2712-2718
- https://doi.org/10.1128/iai.00115-09
Abstract
Staphylococcus aureus pneumonia is one of the most common invasive diseases caused by this human pathogen. S. aureus alpha-hemolysin, a pore-forming cytotoxin, is an essential virulence factor in the pathogenesis of pneumonia. Vaccine-based targeting of this toxin provides protection against lethal staphylococcal pneumonia in a murine model system, suggesting that a monoclonal antibody-based therapy may likewise prove to be efficacious for prevention and treatment of this disease. We report the generation of two distinct anti-alpha-hemolysin monoclonal antibodies that antagonize toxin activity, preventing human lung cell injury in vitro and protecting experimental animals against lethal S. aureus pneumonia. Each of these two monoclonal antibodies recognized an epitope within the first 50 amino acid residues of the mature toxin and blocked the formation of a stable alpha-hemolysin oligomer on the target cell surface. Active immunization with the first 50 amino acids of the toxin also conferred protection against S. aureus pneumonia. Together, these data reveal passive and active immunization strategies for prevention or therapy of staphylococcal pneumonia and highlight the potential role that a critical epitope may play in defining human susceptibility to this deadly disease.Keywords
This publication has 40 references indexed in Scilit:
- Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic reviewEuropean Respiratory Journal, 2008
- Vaccine protection againstStaphylococcus aureuspneumoniaThe Journal of Experimental Medicine, 2008
- CommentaryAnnals of Emergency Medicine, 2007
- Update on Emerging Infections: News from the Centers for Disease Control and PreventionAnnals of Emergency Medicine, 2007
- Surface Proteins and Exotoxins Are Required for the Pathogenesis ofStaphylococcus aureusPneumoniaInfection and Immunity, 2007
- Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumoniaCritical Care, 2006
- The Economic Impact ofStaphylococcus aureusInfection in New York City HospitalsEmerging Infectious Diseases, 1999
- Structure of Staphylococcal α-Hemolysin, a Heptameric Transmembrane PoreScience, 1996
- Key Residues for Membrane Binding, Oligomerization, and Pore Forming Activity of Staphylococcal α-Hemolysin Identified by Cysteine Scanning Mutagenesis and Targeted Chemical ModificationJournal of Biological Chemistry, 1995
- Comparison of anti-alpha-haemolysin and teichoic acid antibody tests in patients with Staphylococcus aureus endocarditis or bacteraemiaJournal of Infection, 1984